Apricus Biosciences Shares Outstanding 2006-2018 | APRI

Current and historical number of shares outstanding for Apricus Biosciences (APRI) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Apricus Biosciences Annual Shares Outstanding
(Millions of US $)
2017 $12
2016 $7
2015 $5
2014 $4
2013 $3
2012 $3
2011 $2
2010 $1
2009 $9
2008 $1
2007 $1
2006 $0
2005 $0
Apricus Biosciences Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $23
Q1 2018 $16
Q4 2017 $12
Q3 2017 $13
Q2 2017 $11
Q1 2017 $8
Q4 2016 $7
Q3 2016 $7
Q2 2016 $6
Q1 2016 $6
Q4 2015 $5
Q3 2015 $5
Q2 2015 $5
Q1 2015 $5
Q4 2014 $4
Q3 2014 $4
Q2 2014 $4
Q1 2014 $4
Q4 2013 $4
Q3 2013 $4
Q2 2013 $3
Q1 2013 $3
Q4 2012 $3
Q3 2012 $3
Q2 2012 $3
Q1 2012 $2
Q4 2011 $2
Q3 2011 $2
Q2 2011 $2
Q1 2011 $2
Q4 2010 $2
Q3 2010 $1
Q2 2010 $1
Q1 2010 $1
Q4 2009 $9
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $1
Q3 2008 $1
Q2 2008 $1
Q1 2008 $1
Q4 2007 $0
Q3 2007 $1
Q2 2007 $1
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.006B
Apricus Bio operates in the pharmaceutical industry and focuses on research and development in the area of drug delivery. Its proprietary drug delivery technology is called NexACT ?. Backed by revenue generating CRO business, Bio-Quant, Inc. and its NexMed USA subsidiary, Apricus Bio has leveraged the flexibility of its proven NexACT? drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer. Apricus Bio was formerly known as NexMed, Inc and is headquartered in San Diago, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.800B 10.97
Zoetis (ZTS) United States $44.072B 31.98
Grifols (GRFS) Spain $13.984B 18.12
Jazz Pharmaceuticals (JAZZ) Ireland $10.500B 15.45
Neurocrine Biosciences (NBIX) United States $10.370B 0.00
Nektar Therapeutics (NKTR) United States $10.353B 12.10
Sage Therapeutics (SAGE) United States $7.097B 0.00
Ionis Pharmaceuticals (IONS) United States $6.979B 0.00
Impax Laboratories (AMRX) United States $6.423B 0.00
United Therapeutics (UTHR) United States $5.472B 7.03
Catalent (CTLT) United States $5.459B 25.42
FibroGen (FGEN) United States $5.119B 0.00
Loxo Oncology (LOXO) United States $4.825B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.233B 16.39
Madrigal Pharmaceuticals (MDGL) United States $3.654B 0.00
Endo (ENDP) Ireland $3.502B 5.03
USANA Health Sciences (USNA) United States $3.141B 27.67
Heron Therapeutics (HRTX) United States $2.962B 0.00
Aerie Pharmaceuticals (AERI) United States $2.892B 0.00
Tilray (TLRY) United States $2.817B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.800B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.414B 0.00
Xencor (XNCR) United States $2.231B 0.00
PTC Therapeutics (PTCT) United States $1.978B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.899B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.794B 21.94
Zogenix (ZGNX) United States $1.741B 0.00
Portola Pharmaceuticals (PTLA) United States $1.691B 0.00
TESARO (TSRO) United States $1.580B 0.00
Corcept Therapeutics (CORT) United States $1.499B 23.07
Theravance Biopharma (TBPH) Cayman Islands $1.497B 0.00
ImmunoGen (IMGN) United States $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.290B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.277B 0.00
Endocyte (ECYT) United States $1.256B 0.00
TherapeuticsMD (TXMD) United States $1.248B 0.00
Karyopharm Therapeutics (KPTI) United States $1.084B 0.00
Tricida (TCDA) United States $1.000B 0.00
Radius Health (RDUS) United States $0.909B 0.00
Flexion Therapeutics (FLXN) United States $0.829B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.777B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.752B 0.00
ArQule (ARQL) United States $0.682B 0.00
Dova Pharmaceuticals (DOVA) United States $0.661B 0.00
CASI Pharmaceuticals (CASI) United States $0.661B 0.00
Siga Technologies (SIGA) United States $0.639B 0.00
GlycoMimetics (GLYC) United States $0.625B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.599B 0.00
OptiNose (OPTN) United States $0.569B 0.00
Collegium Pharmaceutical (COLL) United States $0.559B 0.00
Majesco Entertainment (COOL) United States $0.545B 0.00
ChemoCentryx (CCXI) United States $0.542B 32.44
Lannett Co Inc (LCI) United States $0.513B 4.72
Odonate Therapeutics (ODT) United States $0.512B 0.00
Aclaris Therapeutics (ACRS) United States $0.485B 0.00
Xeris Pharmaceuticals (XERS) United States $0.480B 0.00
Translate Bio (TBIO) United States $0.473B 0.00
Forty Seven (FTSV) United States $0.464B 0.00
Depomed (ASRT) United States $0.462B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.454B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.449B 0.00
Akebia Therapeutics (AKBA) United States $0.448B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.436B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.433B 0.00
Dermira (DERM) United States $0.404B 0.00
Aquestive Therapeutics (AQST) United States $0.392B 0.00
ElectroCore (ECOR) United States $0.385B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.379B 25.83
Concert Pharmaceuticals (CNCE) United States $0.373B 0.00
Mast Therapeutics (SVRA) United States $0.372B 0.00
Minerva Neurosciences (NERV) United States $0.345B 0.00
Neon Therapeutics (NTGN) United States $0.337B 0.00
Zafgen (ZFGN) United States $0.335B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.298B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.282B 0.00
Opexa Therapeutics (ACER) United States $0.281B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.277B 0.00
Achaogen (AKAO) United States $0.268B 0.00
Ardelyx (ARDX) United States $0.245B 0.00
Jounce Therapeutics (JNCE) United States $0.244B 0.00
Aratana Therapeutics (PETX) United States $0.242B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.238B 0.00
Tyme Technologies (TYME) United States $0.237B 0.00
Melinta Therapeutics (MLNT) United States $0.232B 0.00
Ocular Therapeutix (OCUL) United States $0.232B 0.00
IMV INC (IMV) Canada $0.229B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.226B 0.00
DURECT (DRRX) United States $0.212B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Adherex Technologies (FENC) United States $0.184B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.182B 0.00
Cardiome Pharma (CORV) Canada $0.179B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.173B 0.00
MediWound (MDWD) Israel $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Neos Therapeutics (NEOS) United States $0.169B 0.00
KalVista Pharmaceuticals (KALV) United States $0.164B 0.00
Calithera Biosciences (CALA) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.158B 0.00
Immune Design (IMDZ) United States $0.157B 0.00
ContraFect (CFRX) United States $0.154B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.151B 0.00
Aldeyra Therapeutics (ALDX) United States $0.150B 0.00
Molecular Templates (MTEM) United States $0.141B 0.00
MEI Pharma (MEIP) United States $0.137B 0.00
Forward Pharma (FWP) Denmark $0.134B 0.00
ProNAi Therapeutics (SRRA) Canada $0.134B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
Recro Pharma (REPH) United States $0.127B 0.00
SteadyMed (STDY) Israel $0.124B 0.00
Iterum Therapeutics (ITRM) Ireland $0.121B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.116B 0.00
Infinity Pharmaceuticals (INFI) United States $0.114B 0.00
CTI BioPharma (CTIC) United States $0.106B 0.00
Affimed (AFMD) Germany $0.100B 0.00
BioLineRx (BLRX) Israel $0.094B 0.00
Otonomy (OTIC) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
KemPharm (KMPH) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 9.51
Oasmia Pharmaceutical AB (OASM) Sweden $0.073B 0.00
Trillium Therapeutics (TRIL) Canada $0.071B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Novan (NOVN) United States $0.064B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
Capnia (SLNO) United States $0.052B 0.00
Mannatechorporated (MTEX) United States $0.049B 25.82
Tokai Pharmaceuticals (NVUS) United States $0.046B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Avenue Therapeutics (ATXI) United States $0.039B 0.00
Onconova Therapeutics (ONTX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Biomerica (BMRA) United States $0.031B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
Xenetic Biosciences (XBIO) United States $0.028B 0.00
Shineco (TYHT) China $0.025B 2.16
XTL Biopharmaceuticals (XTLB) Israel $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.021B 0.00
Aradigm (ARDM) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Midatech Pharma (MTP) United Kingdom $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Egalet (EGLT) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Skyline Medical (AIPT) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.013B 0.00
PharmAthene (ALT) United States $0.013B 0.00
Intellipharmaceutics (IPCI) Canada $0.012B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.007B 0.00
Pain Therapeutics (PTIE) United States $0.006B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.83
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00